Exane Derivatives

SEC CIK: 0001623883
Latest filing: Jul 12, 2022

SEC filings (opens in a new tab)

WST holding history

West Pharmaceutical Services Inc in every 13F filed by Exane Derivatives, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

WST overview All 13F holders of WST Full Q2 2022 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2021

Holdings of WST by Exane Derivatives, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−455−100.0%	Sold out	Holders
Q1 2022	455	$186.9K	0.1%	+455	New	Holders
Q4 2021	0	$0	0.0%	−5−100.0%	Sold out	Holders
Q3 2021	5	$2.12K	<0.1%	+5	New	Holders